SCD Pharm signs total KRW 700 billion export agreement with U.S. Glenmark
Sam Chun Dang Pharm(CEO Jeon-Kyo Park, SCD Pharm) signed a export agreement of its generic eye drop with U.S. Glenmark on the 20th. The export agreement is the 2nd largest export agreement after the last KRW 400 billion agreement with U.S. BPI.
The term of agreement is 10 years after completing ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
